National Health Determination under paragraph 98C(1)(b) Amendment 2018 (No. 7) (PB 92 of 2018) (Cth)

PB 92 of 2018

National Health Determination under paragraph 98C(1)(b) Amendment 2018 (No. 7)

National Health Act 1953

___________________________________________________________________________

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated   25^th October 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2018 (No. 7).

(2)This Instrument may also be cited as PB 92 of 2018.

1. Commencement

This Instrument commences on 1 November 2018.

1. Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).

Schedule 1     Amendments

1. Schedule 3, after entry for Hydromorphone in the form Tablet (modified release) containing hydromorphone hydrochloride 64 mg

insert:

Oral liquid containing hydromorphone hydrochloride 1 mg per mL, 200 mL

1. Schedule 4, entry for Betaxolol

omit:

Eye drops, suspension, 2.5 mg (as hydrochloride) per mL, 5 mL

1. Schedule 4, after entry for Dexamethasone in the form Eye drops 1 mg per mL, 5 mL

insert:

Intravitreal injection 700 micrograms